THE M6A SIGNATURES INDICATED IMMUNOTHERAPY RESPONSE AND CLINICAL PROGNOSIS OF NON-SMALL CELL LUNG CANCER

被引：0
|
作者：
Peng, Z. [1 ]
机构：
[1] Xi An Jiao Tong Univ, Affiliated Hosp 1, Canc Ctr, Dept Thorac Surg & Oncol, Xian, Shaanxi, Peoples R China
来源：
CHEST | 2022年 / 161卷 / 06期
基金：
美国国家科学基金会;
关键词：
RNA methylation of Non-small cell lung cancer;
D O I：
10.1016/j.chest.2021.12.365
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：335A / 335A
页数：1
相关论文
共 50 条
  • [1] M6A regulator expression patterns predict the immune microenvironment and prognosis of non-small cell lung cancer
    Liu, Xue
    Ma, Changsheng
    Liu, Hui
    Sun, Zhiqiang
    Luo, Judong
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (10) : 2803 - 2814
  • [2] M6A regulator expression patterns predict the immune microenvironment and prognosis of non-small cell lung cancer
    Xue Liu
    Changsheng Ma
    Hui Liu
    Zhiqiang Sun
    Judong Luo
    Journal of Cancer Research and Clinical Oncology, 2022, 148 : 2803 - 2814
  • [3] Clinical implications of mixed response on prognosis of non-small cell lung cancer (NSCLC) patients treated with Immunotherapy
    Lee, Seyoung
    Um, Taegyu
    Lee, Jeeyeon
    Kim, Peter Haseok
    Yadav, Monica
    Chuchuca, Maria J.
    Chung, Liam Il-Young
    Chae, Young Kwang
    CANCER RESEARCH, 2024, 84 (06)
  • [4] NLCIPS: Non-Small Cell Lung Cancer Immunotherapy Prognosis Score
    Song, Peng
    Yang, Dongliang
    Cui, Xiaoxia
    Wang, Hanping
    Si, Xiaoyan
    Zhang, Xiaotong
    Zhang, Li
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 5975 - 5985
  • [5] m6A regulators featured by tumor immune microenvironment landscapes and correlated with immunotherapy in non-small cell lung cancer (NSCLC)
    Yuan, Baowen
    Qin, Hao
    Zhang, Jingyao
    Zhang, Min
    Yang, Yunkai
    Teng, Xu
    Yu, Hefen
    Huang, Wei
    Wang, Yan
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [6] Immunotherapy in non-small cell lung cancer: the clinical impact of immune response and targeting
    Mountzios, Giannis
    Linardou, Helena
    Kosmidis, Paris
    ANNALS OF TRANSLATIONAL MEDICINE, 2016, 4 (14)
  • [7] Clinical factors and prognosis in non-small cell lung cancer
    Martins, SJ
    Pereira, JR
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1999, 22 (05): : 453 - 457
  • [8] Dissecting the m6A methylation affection on afatinib resistance in non-small cell lung cancer
    Meng, Qianqian
    Wang, Shuyuan
    Zhou, Shunheng
    Liu, Haizhou
    Ma, Xueyan
    Zhou, Xu
    Liu, Hui
    Xu, Chaohan
    Jiang, Wei
    PHARMACOGENOMICS JOURNAL, 2020, 20 (02): : 227 - 234
  • [9] Dissecting the m6A methylation affection on afatinib resistance in non-small cell lung cancer
    Qianqian Meng
    Shuyuan Wang
    Shunheng Zhou
    Haizhou Liu
    Xueyan Ma
    Xu Zhou
    Hui Liu
    Chaohan Xu
    Wei Jiang
    The Pharmacogenomics Journal, 2020, 20 : 227 - 234
  • [10] DELINEATION OF SPATIAL TISSUE SIGNATURES OF IMMUNOTHERAPY RESPONSE GROUPS IN NON-SMALL CELL LUNG CANCER (NSCLC)
    Kulasinghe, Arutha
    Monkman, James
    Kim, Honesty
    Mayer, Aaron
    Mehdi, Ahmed
    Cumberbatch, Marie
    Bhagat, Milan
    Schneider, Fabian
    Thaagard, Jeppe
    Mansfield, James
    Ladwa, Rahul
    Mueller, Scott
    Adams, Mark
    O'byrne, Kenneth
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A130 - A130
12345